Clinical trial Recruiting at 1 site Observational Ages 18 and up

Role of Visual Attention and Environment on Real-World Walking for People With Lower Limb Amputation

Official title: The Role of Visual Attention and Environmental Complexity in Real-world Mobility for People With Lower Limb Amputation

Run by Virginia Commonwealth University · NCT07831707 · Data updated 2026-11-12

This study tests how vision-based thinking and different walking environments affect real-world gait in people with a leg amputation.

More Lower Limb Amputation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Locations1 site (Richmond, Virginia)
StatusRecruiting
StartedOctober 25, 2025
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT07831707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with unilateral transtibial amputation, at least 9 months post-amputation, able to walk for 2 minutes, and with 20/60 vision or better.

Probably not a fit

Individuals with contralateral above-knee amputation, recent concussion, active cancer treatment, or inability to follow three-step commands may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how visual attention and cognitive-motor demands influence gait speed and gaze behavior in everyday walking among adults with unilateral lower limb amputation. It examines performance under varying terrain complexities and both vision-based and non-vision-based dual-tasks to better reflect real-world mobility. Data will include walking patterns and eye movements collected during tasks that mimic daily navigation, complementing standard clinical assessments. The goal is to identify factors that limit real-world mobility despite prosthesis advances and to inform more ecologically valid rehabilitation approaches.

Why it matters

Potential benefit: findings could lead to improved assessment methods and targeted rehab strategies that address real-world mobility challenges for people with lower limb amputation.

How similar studies have gone: Prior dual-task research in other populations supports the value of ecologically valid mobility assessments; applicability to lower limb amputation is being explored and remains a developing area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* unilateral transtibial LLA of either dysvascular (diabetes, peripheral vascular disease, and/or infection) or traumatic etiology
* 18 years old minimum
* able to ambulate 2 minutes without rest
* 9 months since LLA
* fitted with terminal prosthesis
* 20/60 vision or better (with or without glasses/contacts)

Exclusion Criteria:

* congenital or cancer-related LLA
* ankle-level or above LLA on the contralateral limb
* residual limb wound or contralateral foot ulcer
* unstable heart condition (including unstable angina, uncontrolled cardiac dysrhythmia, acute myocarditis, hypertension, and acute pericarditis)
* acute systemic infection
* prisoner
* inability to follow a 3-step command
* concussion/brain injury in the past 12 months
* active cancer treatment
* preexisting neurological condition (i.e., multiple sclerosis, Parkinson's disease)
* participating in prosthetic rehabilitation
* color-blindness
* history of seizure(s)
* inability to read and communicate in English.

Participants in the control group must meet the non-amputation-related criteria noted above, be within ±2 years and the same biological sex as their paired participants with LLA.

Where it's running

  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Paul Kline — Virginia Commonwealth University
  • Study coordinator: Paul Kline
  • Email: klinep@vcu.edu
  • Phone: 804-828-4483

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.